KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EPS (Basic) (2019 - 2026)

Hims & Hers Health's EPS (Basic) history spans 8 years, with the latest figure at -$0.4 for Q1 2026.

  • On a quarterly basis, EPS (Basic) fell 281.82% to -$0.4 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.05, a 106.76% decrease, with the full-year FY2025 number at $0.57, down 1.72% from a year prior.
  • EPS (Basic) hit -$0.4 in Q1 2026 for Hims & Hers Health, down from $0.09 in the prior quarter.
  • Over the last five years, EPS (Basic) for HIMS hit a ceiling of $0.35 in Q3 2024 and a floor of -$0.4 in Q1 2026.
  • Historically, EPS (Basic) has averaged $0.02 across 5 years, with a median of $0.01 in 2023.
  • Biggest five-year swings in EPS (Basic): surged 1000.0% in 2024 and later plummeted 281.82% in 2026.
  • Tracing HIMS's EPS (Basic) over 5 years: stood at -$0.05 in 2022, then soared by 120.0% to $0.01 in 2023, then surged by 1000.0% to $0.11 in 2024, then decreased by 18.18% to $0.09 in 2025, then crashed by 544.44% to -$0.4 in 2026.
  • Business Quant data shows EPS (Basic) for HIMS at -$0.4 in Q1 2026, $0.09 in Q4 2025, and $0.07 in Q3 2025.